CLINICAL_TRIALS trial_result · 2014-10-15

Clinical Trial Update: VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia [Phase 3]

Phase 3 trial of VEC-162 in healthy adults using an insomnia model has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vanda Pharmaceuticals | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2014-10-15